ALFA Finder| Revenue growth | FY26 growth at 16% YoY; Q4 growth at 10% YoY. |
|---|---|
| Margins | FY26 EBITDA margin at 26.2%; Q4 margin at 26.8%. |
| Demand visibility | Strong, with network occupancy maintained above 75% despite capacity additions. |
| Management confidence | High confidence in North India demand and brownfield expansion leverage. |
Growth
FY26 gross revenue reached INR 10,538 Cr (+16% YoY) with operating EBITDA growing 14% to INR 2,638 Cr.
Outlook
Investing INR 1,400 Cr in 700-bed Lucknow hospital; targeting 500-bed Gurgaon commissioning by end of FY27.
Risks
Discontinuation of high-value chemo drugs impacted oncology revenues; ALOS temporarily higher due to capacity rollouts.
Earnings Call filed with NSE, NSE: MAXHEALTH. Summary written with AI assistance from the document.
Max Healthcare Institute Ltd: key numbers
- Share price
- ₹926.90
- Market cap
- ₹90,218 Cr
- Revenue (annual)
- ₹8,373 Cr
- Net profit (annual)
- ₹1,442 Cr
- P/E (TTM)
- 65.3×Sector 54.5×
- Promoter holding
- 23.71%+0.00% QoQ
- FII holding
- 40.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Max Healthcare Institute Ltd
All →Max Healthcare Institute Earnings Call Transcript: Key Takeaways
Max Healthcare maintains strong momentum with 20% revenue growth, driven by rapid brownfield ramp-ups and improved ARPOB despite a 14% capacity increase.
Max Healthcare Institute Management Change
Max Healthcare appointed Dharmender Kumar as Director and Chief - Public Affairs, effective November 1, 2026. The change was approved at the October 30, 2026 board meeting.
Max Healthcare Institute Capacity Expansion: ₹97 Cr Investment
Max Healthcare will add 60 beds through two new floors at its Vaishali hospital. The Rs.97 Crore project is internally funded and due within 24 months.
- Value
- ₹97.00 Cr
- Execution
- Within 24 months
- hospital beds
- 60.0 beds
Max Healthcare Institute Capacity Expansion: ₹93 Cr Investment
Max Healthcare approved adding about 85 beds at its Noida hospital through redevelopment, at a cost of Rs 93 Crore funded by internal accruals. Commissioning is planned within 15 months.
- Value
- ₹93.00 Cr
- Execution
- Within 15 months
- hospital beds
- 85.0 beds
Max Healthcare Institute Results Update
Max Healthcare Q2 FY27 revenue rose to ₹3,219 Cr, up 20% YoY, with PAT at ₹448 Cr. Board approved ₹415 Cr capex for 209 additional beds.
- hospital beds approved for addition
- 209 beds
Max Healthcare Institute Q2 FY27 Results: Net Profit ₹414.4 Cr, Down 15.7% YoY
Max Healthcare Institute Ltd reported revenue from operations of ₹2,569 Cr (+20.3% YoY) and net profit of ₹414.4 Cr (-15.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹414.4 Cr · -15.7% YoY